In vivo, pirfenidone treatment in Pkd1RC/RC mice reduced renal fibrosis, collagen deposition, myofibroblast accumulation, pro-fibrotic gene expression and decreased TGF-β/SMAD3 and mTOR signaling. This evidence concerns the gene SMAD3 and renal fibrosis.